• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切缘之外:世界卫生组织2级颅内脑膜瘤的复发模式

Beyond the Surgical Margin: Patterns of Recurrence in World Health Organization Grade 2 Intracranial Meningiomas.

作者信息

Obiri-Yeboah Derrick, Soni Pranay, Oyem Precious C, Almeida João Paulo, Murayi Roger, Recinos Pablo F, Kshettry Varun R

机构信息

Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.

Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA; Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

World Neurosurg. 2023 Sep;177:e593-e599. doi: 10.1016/j.wneu.2023.06.100. Epub 2023 Jun 28.

DOI:10.1016/j.wneu.2023.06.100
PMID:37390903
Abstract

OBJECTIVE

To characterize and classify the location of recurrence in surgically resected World Health Organization (WHO) grade 2 intracranial meningiomas that did not receive adjuvant radiation and compare the recurrence pattern of those who underwent gross total resection (GTR) versus subtotal resection (STR).

METHODS

We performed a retrospective review of patients who underwent surgical resection of a newly diagnosed WHO grade 2 meningioma at our institution between 1996 and 2019. Patients who were observed postoperatively without adjuvant radiation and subsequently developed a recurrence were included in the study. All patients who received adjuvant therapy were excluded. Recurrence was defined as any evidence of radiographic progression on postoperative surveillance magnetic resonance imaging. Location of recurrence was categorized as follows: 1) central-growth observed inside the area of the previously resected tumor more than 1 cm inside the original tumor margin; 2) marginal-growth observed within 1 cm (inside or outside) of the original tumor margin; and 3) remote-growth observed >1 cm outside the original tumor margin. Patterns of recurrence were evaluated by 2 observers after coregistering preoperative and postoperative magnetic resonance imaging, and any differences were reconciled by discussion.

RESULTS

A total of 22 patients matched the inclusion criteria. Twelve (55%) underwent GTR, and 10 (45%) underwent STR. In 12 patients in whom GTR was achieved, the mean preoperative tumor volume was 50.6 cm, with 5 (41.7%) in a skull base location. The average time to recurrence for these tumors was 22.7 months, with a mean recurrent tumor volume of 9.0 cm. Ten patients (83.3%) had central recurrence, 11 patients (91.7%) had marginal recurrence, and only 4 patients (33.3%) had remote recurrence. In 10 patients in whom STR was achieved, mean preoperative tumor volume was 44.8 cm, with 7 (70.0%) in a skull base location. The average time to recurrence for these tumors was 23.0 months, with a mean recurrent tumor volume of 21.8 cm. Of these 10 patients, 9 (90.0%) had central recurrence, all 10 (100.0%) had marginal recurrence, and only 4 (40.0%) patients had remote recurrence.

CONCLUSIONS

The present study evaluating patterns of recurrence for WHO grade 2 meningiomas after surgical resection (GTR or STR) showed that recurrence occurred centrally and/or at the original tumor margin, with only a few recurring >1 cm outside the original tumor margin. The results of this study suggest that treatment, whether initial surgical resection or adjuvant radiation, may benefit from including at least a 1-cm dural margin when safe, to optimize tumor control, but further clinical study is needed.

摘要

目的

对未接受辅助放疗的世界卫生组织(WHO)2级颅内脑膜瘤手术切除后的复发部位进行特征描述和分类,并比较接受全切除(GTR)与次全切除(STR)患者的复发模式。

方法

我们对1996年至2019年间在我院接受新诊断的WHO 2级脑膜瘤手术切除的患者进行了回顾性研究。术后未接受辅助放疗且随后出现复发的患者纳入本研究。所有接受辅助治疗的患者均被排除。复发定义为术后监测磁共振成像上任何影像学进展的证据。复发部位分类如下:1)中央生长,在先前切除肿瘤区域内、距原始肿瘤边缘1 cm以上观察到;2)边缘生长,在原始肿瘤边缘1 cm内(内侧或外侧)观察到;3)远处生长,在原始肿瘤边缘外>1 cm处观察到。在对术前和术后磁共振成像进行配准后,由2名观察者评估复发模式,任何差异通过讨论协调一致。

结果

共有22例患者符合纳入标准。12例(55%)接受了GTR,10例(45%)接受了STR。在实现GTR的12例患者中,术前平均肿瘤体积为50.6 cm³,其中5例(41.7%)位于颅底。这些肿瘤的平均复发时间为22.7个月,复发肿瘤平均体积为9.0 cm³。10例患者(83.3%)有中央复发,11例患者(91.7%)有边缘复发,只有4例患者(33.3%)有远处复发。在实现STR的10例患者中,术前平均肿瘤体积为44.8 cm³,其中7例(70.0%)位于颅底。这些肿瘤的平均复发时间为23.0个月,复发肿瘤平均体积为21.8 cm³。在这10例患者中,9例(90.0%)有中央复发,所有10例(100.0%)有边缘复发,只有4例(40.0%)患者有远处复发。

结论

本研究评估WHO 2级脑膜瘤手术切除(GTR或STR)后的复发模式显示,复发发生在中央和/或原始肿瘤边缘,只有少数在原始肿瘤边缘外>1 cm处复发。本研究结果表明,无论是初始手术切除还是辅助放疗,在安全的情况下,治疗可能受益于至少包含1 cm的硬脑膜边缘,以优化肿瘤控制,但需要进一步的临床研究。

相似文献

1
Beyond the Surgical Margin: Patterns of Recurrence in World Health Organization Grade 2 Intracranial Meningiomas.手术切缘之外:世界卫生组织2级颅内脑膜瘤的复发模式
World Neurosurg. 2023 Sep;177:e593-e599. doi: 10.1016/j.wneu.2023.06.100. Epub 2023 Jun 28.
2
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.中危脑膜瘤:NRG 肿瘤学 RTOG 0539 的初步结果。
J Neurosurg. 2018 Jul;129(1):35-47. doi: 10.3171/2016.11.JNS161170. Epub 2017 Oct 6.
3
Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas.保留面神经的小脑桥脑角脑膜瘤治疗方法的疗效和结果。
J Neurosurg. 2017 Dec;127(6):1231-1241. doi: 10.3171/2016.10.JNS161982. Epub 2017 Feb 10.
4
Assessment of Local and Regional Control in High-Risk Atypical (WHO Grade 2) Meningiomas Receiving Stereotactic Fractionated Radiosurgery.接受立体定向分次放射外科治疗的高危非典型(世界卫生组织2级)脑膜瘤的局部和区域控制评估
Cureus. 2025 Jan 12;17(1):e77322. doi: 10.7759/cureus.77322. eCollection 2025 Jan.
5
Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.与非颅底脑膜瘤相比,手术切除的颅底脑膜瘤具有不同的术后复发模式。
J Neurosurg. 2016 Aug;125(2):431-40. doi: 10.3171/2015.7.JNS15546. Epub 2016 Jan 1.
6
Extent of resection and survival outcomes in World Health Organization grade II meningiomas.世界卫生组织(II 级)脑膜瘤的切除范围与生存结局。
J Neurooncol. 2021 Jan;151(2):173-179. doi: 10.1007/s11060-020-03632-3. Epub 2020 Nov 17.
7
Atypical meningiomas: is postoperative radiotherapy indicated?非典型脑膜瘤:是否需要术后放疗?
Neurosurg Focus. 2013 Dec;35(6):E15. doi: 10.3171/2013.9.FOCUS13325.
8
Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.挽救性手术联合或不联合再次放疗对先前放疗后复发的颅底脑膜瘤的影响。
J Neurosurg. 2023 Feb 3;139(3):798-809. doi: 10.3171/2022.12.JNS222010. Print 2023 Sep 1.
9
Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.复发性颅内脑膜瘤再行放射外科治疗的结果分析
Clin Neurol Neurosurg. 2017 Feb;153:93-101. doi: 10.1016/j.clineuro.2016.12.014. Epub 2016 Dec 29.
10
Skull base atypical meningioma: long term surgical outcome and prognostic factors.颅底非典型脑膜瘤:长期手术结果及预后因素
Clin Neurol Neurosurg. 2015 Jan;128:112-6. doi: 10.1016/j.clineuro.2014.11.009. Epub 2014 Nov 24.

引用本文的文献

1
VCAN in the extracellular matrix drives glioma recurrence by enhancing cell proliferation and migration.细胞外基质中的VCAN通过增强细胞增殖和迁移来驱动胶质瘤复发。
Front Neurosci. 2024 Nov 1;18:1501906. doi: 10.3389/fnins.2024.1501906. eCollection 2024.
2
Topographic Patterns of Intracranial Meningioma Recurrences-Systematic Review with Clinical Implication.颅内脑膜瘤复发的地形学模式——具有临床意义的系统评价
Cancers (Basel). 2024 Jun 19;16(12):2267. doi: 10.3390/cancers16122267.
3
Single versus multiple reoperations for recurrent intracranial meningiomas.
单发脑膜瘤与复发性颅内脑膜瘤的多次手术治疗。
J Neurooncol. 2024 Jul;168(3):527-535. doi: 10.1007/s11060-024-04673-8. Epub 2024 Apr 24.
4
Grading meningioma resections: the Simpson classification and beyond.脑膜瘤切除术分级:辛普森分类法及其他方法。
Acta Neurochir (Wien). 2024 Jan 23;166(1):28. doi: 10.1007/s00701-024-05910-9.